Omega Fund V GP Manager, Ltd.'s Net Worth

Estimate Recalculated Jun 20, 2025 09:17PM EST

Who is Omega Fund V GP Manager, Ltd.

Omega Fund V GP Manager, Ltd. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., Morphic Holding, Inc., IMMUNIC, INC., Gossamer Bio, Inc., Kronos Bio, Inc., Translate Bio, Inc., and Trevi Therapeutics, Inc..

SEC CIK

Omega Fund V GP Manager, Ltd.'s CIK is 0001641348

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nuvation Bio Inc.

Investor

Updated Apr 07, 2022

View Quote Details


Form 4	-10.89%	-2.50M	$5.60	-$14.00M	Apr 07, 2022	20.46M	Sale	—	Apr 05
Form 4	-2.13%	-500.00K	$10.07	-$5.03M	Dec 17, 2021	22.96M	Sale	—	Dec 15
Form 4	-5.63%	-1.40M	$9.80	-$13.72M	Dec 09, 2021	23.46M	Sale	—	Dec 07
Form 4	-0.59%	-295.04K	$9.75	-$2.88M	Nov 24, 2021	49.71M	Sale	—	Nov 22 - Nov 23
Form 4	-7.37%	-2.00M	$9.25	-$18.50M	Nov 05, 2021	25.15M	Sale	—	Nov 03
Form 4	-3.76%	-1.06M	$9.59	-$10.16M	Nov 01, 2021	27.15M	Sale	—	Oct 28 - Oct 29
Form 4	1.80%	500.00K	$10.00	—	Feb 12, 2021	28.21M	Options	—	Feb 10
Form 3	—	—	—	—	Feb 12, 2021	—	—	—	—

Showing 8 results

Morphic Holding, Inc.

Investor

Updated May 03, 2021

View Quote Details


Form 4	-0.82%	-17.16K	$54.65	-$937.66K	May 03, 2021	2.07M	Sale	Scheduled	Apr 29 - Apr 30
Form 4	-0.51%	-10.70K	$55.42	-$593.25K	Apr 29, 2021	2.09M	Sale	Scheduled	Apr 27 - Apr 28
Form 4	-0.65%	-13.82K	$56.00	-$773.77K	Apr 27, 2021	2.10M	Sale	Scheduled	Apr 23 - Apr 26
Form 4	-0.93%	-19.79K	$57.07	-$1.13M	Apr 23, 2021	2.11M	Sale	Scheduled	Apr 21 - Apr 22
Form 4	-0.83%	-17.87K	$54.30	-$970.51K	Apr 21, 2021	2.13M	Sale	Scheduled	Apr 19 - Apr 20
Form 4	-0.82%	-17.75K	$55.62	-$987.12K	Apr 19, 2021	2.15M	Sale	Scheduled	Apr 15 - Apr 16
Form 4	-0.96%	-20.94K	$57.49	-$1.20M	Apr 15, 2021	2.17M	Sale	Scheduled	Apr 13 - Apr 14
Form 4	-1.12%	-24.81K	$58.00	-$1.44M	Apr 13, 2021	2.19M	Sale	Scheduled	Apr 09 - Apr 12
Form 4	-1.19%	-26.68K	$60.79	-$1.62M	Apr 09, 2021	2.21M	Sale	Scheduled	Apr 07 - Apr 08
Form 4	-0.90%	-20.42K	$61.58	-$1.26M	Apr 07, 2021	2.24M	Sale	Scheduled	Apr 05 - Apr 06
Form 4	-1.33%	-30.41K	$63.93	-$1.94M	Apr 02, 2021	2.26M	Sale	Scheduled	Mar 31 - Apr 01
Form 4	-1.55%	-36.08K	$60.31	-$2.18M	Mar 31, 2021	2.29M	Sale	Scheduled	Mar 29 - Mar 30
Form 4	-2.02%	-47.94K	$58.67	-$2.81M	Mar 29, 2021	2.33M	Sale	Scheduled	Mar 25 - Mar 26
Form 4	-2.16%	-52.31K	$60.52	-$3.17M	Mar 25, 2021	2.37M	Sale	Scheduled	Mar 23 - Mar 24
Form 4	-1.05%	-25.78K	$63.96	-$1.65M	Mar 23, 2021	2.43M	Sale	Scheduled	Mar 19 - Mar 22
Form 4	-0.72%	-35.85K	$64.07	-$2.30M	Mar 19, 2021	4.92M	Sale	Scheduled	Mar 17 - Mar 18
Form 4	-0.85%	-64.39K	$65.95	-$4.19M	Mar 17, 2021	7.52M	Sale	Scheduled	Mar 15 - Mar 16
Form 4	-1.39%	-35.99K	$36.70	-$1.32M	Mar 01, 2021	2.55M	Sale	Scheduled	Feb 25 - Mar 01
Form 4	-0.41%	-10.55K	$34.16	-$360.31K	Feb 25, 2021	2.59M	Sale	Scheduled	Feb 23 - Feb 24
Form 4	-0.42%	-10.86K	$35.18	-$382.04K	Feb 23, 2021	2.60M	Sale	Scheduled	Feb 19 - Feb 22
Form 4	-0.62%	-16.16K	$35.38	-$571.56K	Feb 19, 2021	2.61M	Sale	Scheduled	Feb 17 - Feb 18
Form 4	-0.32%	-8.39K	$36.90	-$309.55K	Feb 17, 2021	2.63M	Sale	Scheduled	Feb 12 - Feb 16
Form 4	-0.38%	-10.07K	$37.63	-$379.02K	Feb 12, 2021	2.63M	Sale	Scheduled	Feb 10 - Feb 11
Form 4	-0.83%	-22.08K	$39.65	-$875.69K	Feb 10, 2021	2.64M	Sale	Scheduled	Feb 08 - Feb 09
Form 4	-0.57%	-15.42K	$38.08	-$587.18K	Feb 08, 2021	2.67M	Sale	Scheduled	Feb 04 - Feb 05
Form 4	-1.97%	-54.12K	$37.05	-$2.01M	Feb 04, 2021	2.69M	Sale	Scheduled	Feb 02 - Feb 03
Form 4	-0.74%	-20.54K	$33.73	-$692.92K	Feb 02, 2021	2.74M	Sale	Scheduled	Jan 29 - Feb 01
Form 4	-0.74%	-20.74K	$32.77	-$679.53K	Jan 29, 2021	2.76M	Sale	Scheduled	Jan 27 - Jan 28
Form 4	-0.28%	-15.91K	$32.28	-$506.50K	Jan 27, 2021	5.57M	Sale	Scheduled	Jan 25 - Jan 26
Form 4	-0.36%	-10.01K	$30.74	-$307.52K	Jan 25, 2021	2.80M	Sale	Scheduled	Jan 21 - Jan 22
Form 4	-0.61%	-17.24K	$30.04	-$517.89K	Jan 21, 2021	2.81M	Sale	Scheduled	Jan 19
Form 4	-0.41%	-23.53K	$30.44	-$718.48K	Jan 19, 2021	5.68M	Sale	Scheduled	Jan 14 - Jan 15
Form 4	-0.44%	-12.50K	$30.11	-$376.26K	Jan 15, 2021	2.85M	Sale	Scheduled	Jan 12 - Jan 13
Form 4	-0.43%	-12.41K	$30.14	-$373.95K	Jan 12, 2021	2.86M	Sale	Scheduled	Jan 08 - Jan 11
Form 4	-0.97%	-28.16K	$30.03	-$845.83K	Jan 08, 2021	2.88M	Sale	Scheduled	Jan 06 - Jan 07
Form 4	-0.87%	-25.44K	$31.85	-$810.39K	Jan 06, 2021	2.90M	Sale	Scheduled	Jan 04 - Jan 05
Form 4	-0.54%	-15.89K	$33.01	-$524.57K	Jan 04, 2021	2.93M	Sale	Scheduled	Dec 30 - Dec 31
Form 4	-0.67%	-19.89K	$32.04	-$637.42K	Dec 30, 2020	2.95M	Sale	Scheduled	Dec 28 - Dec 29
Form 4	-0.40%	-12.03K	$33.21	-$399.38K	Dec 28, 2020	2.97M	Sale	Scheduled	Dec 23 - Dec 24
Form 4	4.70%	133.33K	$15.00	—	Jul 01, 2019	2.97M	Purchase	—	Jul 01
Form 3	—	—	—	—	Jun 26, 2019	—	—	—	—

Showing 41 results

IMMUNIC, INC.

Investor

Updated Apr 22, 2019

View Quote Details


Form 3	—	—	—	—	Apr 22, 2019	1.37M	—	—	—

Showing 1 results

Gossamer Bio, Inc.

Investor

Updated Sep 23, 2019

View Quote Details


Form 4	-2.73%	-183.61K	$21.96	-$4.03M	Sep 23, 2019	6.55M	Sale	—	Sep 20
Form 4	-1.21%	-82.21K	$21.75	-$1.79M	Sep 18, 2019	6.74M	Sale	—	Sep 16 - Sep 18
Form 4	-1.63%	-112.78K	$21.22	-$2.39M	Sep 12, 2019	6.82M	Sale	—	Sep 10 - Sep 11
Form 4	-0.31%	-21.40K	$21.56	-$461.54K	Sep 09, 2019	6.93M	Sale	—	Sep 05 - Sep 06
Form 4	-77.78%	-24.34M	—	—	Feb 12, 2019	6.95M	Options	—	Feb 12
Form 3	—	—	—	—	Feb 07, 2019	—	—	—	—

Showing 6 results

Kronos Bio, Inc.

Investor

Updated Oct 16, 2020

View Quote Details


Form 4	18.85%	605.49K	$17.72	—	Oct 16, 2020	3.82M	Purchase	—	Oct 14
Form 3	—	—	—	—	Oct 08, 2020	19.45K	—	—	—

Showing 2 results

Translate Bio, Inc.

Investor

Updated Jul 03, 2018


Form 4	-82.00%	-22.21M	—	—	Jul 03, 2018	4.88M	Options	—	Jul 02
Form 3	—	—	—	—	Jun 27, 2018	—	—	—	—

Showing 2 results

Trevi Therapeutics, Inc.

Investor

Updated May 13, 2019

View Quote Details


Form 4	-79.30%	-4.07M	$10.00	—	May 13, 2019	1.06M	Buy-Options	—	May 09
Form 3	—	—	—	—	May 07, 2019	—	—	—	—

Showing 2 results